T.P.36
E. Mazzone(Università Cattolica del Sacro Cuore), Eugenio Mercuri(Università Cattolica del Sacro Cuore), Rita De Sanctis(Humanitas University), Lavinia Fanelli(Università Cattolica del Sacro Cuore), Marika Pane(Università Cattolica del Sacro Cuore), Enrico Bertini(Bambino Gesù Children's Hospital), Serena Sivo(Università Cattolica del Sacro Cuore), Concetta Palermo(Università Cattolica del Sacro Cuore), Adele D’Amico(Bambino Gesù Children's Hospital)
Cited by 0
Related Papers
Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection
|Nature Genetics|2006|673
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
|Neuromuscular Disorders|2019|636
Longitudinal effect of eteplirsen versus historical control on ambulation in <scp>D</scp> uchenne muscular dystrophy
|Annals of Neurology|2015|502
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
|The Lancet Oncology|2017|493
Clinical and Molecular Phenotype of Aicardi-Goutières Syndrome
|The American Journal of Human Genetics|2007|449